Interventional Psychiatry of Tampa Bay is a clinical research site located in Tampa, Florida, United States 33629.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Interventional Psychiatry of Tampa Bay has participated in 10 clinical trials with 7 currently active.
Therapeutic areas: Depressive Disorder, Major, Psychosis Associated With Alzheimer's Disease, Schizophrenia.
Sponsors: Janssen Research & Development, LLC, Karuna Therapeutics, Inc., a Bristol Myers Squibb company, Otsuka Pharmaceutical Development & Commercialization, Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Interventional Psychiatry of Tampa Bay has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Interventional Psychiatry of Tampa Bay has 10 clinical trials on record, with 7 currently active. Their work covers Depressive Disorder, Major, Psychosis Associated With Alzheimer's Disease, Schizophrenia.
Yes — Interventional Psychiatry of Tampa Bay holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.